<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="such as amitriptyline, as a first‐line prophylactic medication and receive" exact="topiramate" post="or aprepitant as alternate prophylactic medications. Zonisamide or levetiracetam"/>
 <result pre="amitriptyline, as a first‐line prophylactic medication and receive topiramate or" exact="aprepitant" post="as alternate prophylactic medications. Zonisamide or levetiracetam and mitochondrial"/>
 <result pre="receive topiramate or aprepitant as alternate prophylactic medications. Zonisamide or" exact="levetiracetam" post="and mitochondrial supplements (Coenzyme Q10, L‐carnitine, and riboflavin) are"/>
 <result pre="using serotonin antagonists, such as ondansetron, and/or triptans, such as" exact="sumatriptan" post="or aprepitant to abort symptoms . Emergency department treatment"/>
 <result pre="antagonists, such as ondansetron, and/or triptans, such as sumatriptan or" exact="aprepitant" post="to abort symptoms . Emergency department treatment is best"/>
 <result pre="using serotonin antagonists such as ondansetron, and/or triptans such as" exact="sumatriptan" post="or newer agents such as aprepitant (NK1 receptor antagonist)"/>
 <result pre="and/or triptans such as sumatriptan or newer agents such as" exact="aprepitant" post="(NK1 receptor antagonist) to abort symptoms. An individualized treatment"/>
 <result pre="Amitriptyline (AT) is a tricyclic antidepressant, a mixed serotonin and" exact="norepinephrine" post="reuptake inhibitor that also interacts with cholinergic, and multiple"/>
 <result pre="channels. 11 Amitriptyline is converted by cytochrome P4502C19 (CYP2C19) to" exact="nortriptyline" post="(NT). 12 Both AT and NT are converted by"/>
 <result pre="these patients were also treated with other agents such as" exact="topiramate" post="and mitochondrial supplements such as Co‐Q10 and L‐carnitine. An"/>
 <result pre="and delirium may occur with the treatment of depression with" exact="amitriptyline" post="but are not reported in CVS, perhaps due to"/>
 <result pre="2. We conditionally recommend that adults with moderate‐to‐severe CVS receive" exact="topiramate" post="as an alternate prophylactic medication Grade: Conditional recommendation, very"/>
 <result pre="alternative prophylactic medication in moderate‐to‐severe CVS. Several studies show that" exact="topiramate" post="is effective in preventing migraine headaches, but there is"/>
 <result pre="in CVS. One retrospective study of 16 children treated with" exact="topiramate" post="found that 81% became episode free, 13% showed at"/>
 <result pre="≥50% reduction in frequency/severity of CVS episodes. Some patients on" exact="topiramate" post="were also receiving AT and mitochondrial supplements in this"/>
 <result pre="and mitochondrial supplements in this study. 3 We recommend starting" exact="topiramate" post="at 25 mg daily and titrating by 25 mg"/>
 <result pre="developing renal stones. 39 Female patients should be informed that" exact="topiramate" post="can interfere with the efficacy of oral contraceptives. 3.3"/>
 <result pre="3. We conditionally recommend that adults with moderate‐to‐severe CVS receive" exact="aprepitant" post="as an alternate prophylactic medication Grade: Conditional recommendation, very"/>
 <result pre="severe liver disease. There is a single open‐label trial of" exact="aprepitant" post="used prophylactically to treat CVS in children and adolescents"/>
 <result pre="of 126 adults with gastroparesis (and related syndromes), although oral" exact="aprepitant" post="(125 mg) failed to significantly reduce nausea when measured"/>
 <result pre="Gastroparesis Clinical Symptom Index. 44 Most trials in CINV used" exact="aprepitant" post="in combination with 5HT 3 antagonists and corticosteroids. 45,"/>
 <result pre="and corticosteroids. 45, 46 Nine task force members have used" exact="aprepitant" post="prophylactically in adolescents or adults with some success in"/>
 <result pre="and the clinical experince of committee members, we recommend initiating" exact="aprepitant" post="as an alternate/second‐line prophylactic treatment in patients who are"/>
 <result pre="kg. Costs per capsule of Emend ® ($120‐230) or generic" exact="aprepitant" post="($47‐90) are high and must be considered when prescribing"/>
 <result pre="4. We conditionally recommend that adults with moderate‐to‐severe CVS receive" exact="zonisamide" post="or levetiracetam as an alternate prophylactic medication Grade: Conditional"/>
 <result pre="conditionally recommend that adults with moderate‐to‐severe CVS receive zonisamide or" exact="levetiracetam" post="as an alternate prophylactic medication Grade: Conditional recommendation, very"/>
 <result pre="metabolized before renal excretion. The evidence supporting the use of" exact="zonisamide" post="or levetiracetam as prophylactic therapy in CVS is based"/>
 <result pre="renal excretion. The evidence supporting the use of zonisamide or" exact="levetiracetam" post="as prophylactic therapy in CVS is based on one"/>
 <result pre="± 0.3 to 0.5 ± 0.2 episodes/year in response to" exact="zonisamide" post="or levetiracetam was quite notable. Ultimately, the majority (75%)"/>
 <result pre="to 0.5 ± 0.2 episodes/year in response to zonisamide or" exact="levetiracetam" post="was quite notable. Ultimately, the majority (75%) of patients"/>
 <result pre="was quite notable. Ultimately, the majority (75%) of patients on" exact="zonisamide" post="or levetiracetam reported a moderate clinical response, and 20%"/>
 <result pre="notable. Ultimately, the majority (75%) of patients on zonisamide or" exact="levetiracetam" post="reported a moderate clinical response, and 20% experienced a"/>
 <result pre="switch to the alternative AED very well. The doses of" exact="zonisamide" post="and levetiracetam used for CVS prophylaxis mirror those used"/>
 <result pre="the alternative AED very well. The doses of zonisamide and" exact="levetiracetam" post="used for CVS prophylaxis mirror those used to prevent"/>
 <result pre="established liver or renal disease. Finally, newer AEDs related to" exact="zonisamide" post="and levetiracetam, such as lacosamide or brivaracetam, are now"/>
 <result pre="Finally, newer AEDs related to zonisamide and levetiracetam, such as" exact="lacosamide" post="or brivaracetam, are now available, but it remains to"/>
 <result pre="We conditionally recommend using mitochondrial supplements such as Co‐Q10, and" exact="riboflavin" post="as prophylactic therapy in the treatment of CVS. Mitochondrial"/>
 <result pre="tolerability, and patient satisfaction of Co‐Q10 (n = 32) with" exact="amitriptyline" post="(n = 249) in children with CVS. 19 The"/>
 <result pre="tolerability. 58 In a systematic review of the efficacy of" exact="riboflavin" post="as prophylactic therapy, riboflavin was associated with a positive"/>
 <result pre="systematic review of the efficacy of riboflavin as prophylactic therapy," exact="riboflavin" post="was associated with a positive therapeutic effect in five"/>
 <result pre="adults with migraine. 59 Most migraine studies report doses of" exact="riboflavin" post="of 200 mg twice daily. Based upon this indirect"/>
 <result pre="daily. Based upon this indirect evidence, one may also consider" exact="riboflavin" post="as an additional prophylactic supplement in adult CVS patients."/>
 <result pre="CVS 4.1 Recommendation 6. We conditionally recommend using triptans like" exact="sumatriptan" post="to abort symptoms of a CVS episode Grade: Conditional"/>
 <result pre="producing constriction of distended dural blood vessels. The efficacy of" exact="sumatriptan" post="in migraine is due to multiple sites of action"/>
 <result pre="(vascular, neural, and central). There are reports of efficacy of" exact="sumatriptan" post="in abdominal migraine, a condition classified in the subgroup"/>
 <result pre="non–placebo‐controlled study of 11 children with CVS, the efficacy of" exact="sumatriptan" post="treatment was high in those with a family history"/>
 <result pre="those without a family history of migraine still responded to" exact="sumatriptan" post="in 50% of their attacks. In this study, sumatriptan"/>
 <result pre="to sumatriptan in 50% of their attacks. In this study," exact="sumatriptan" post="was administered by SC injection in nine and via"/>
 <result pre="Although the number of patients was small, the administration of" exact="sumatriptan" post="reduced vomiting in nine patients (82%) and the nasal"/>
 <result pre="effective. Three other case reports describe the efficacy of injectable" exact="sumatriptan" post="in aborting episodes of CVS. 65 The committee believes"/>
 <result pre="in aborting episodes of CVS. 65 The committee believes that" exact="sumatriptan" post="is effective in the acute treatment of CVS although"/>
 <result pre="of CVS although randomized placebo‐controlled studies investigating the efficacy of" exact="sumatriptan" post="in CVS attacks are lacking. We recommend administration of"/>
 <result pre="which can have a bitter taste. 66 We recommend using" exact="sumatriptan" post="as a nasal spray at 20 mg initially, while"/>
 <result pre="nasal spray at 20 mg initially, while a comparable subcutaneous" exact="sumatriptan" post="dose in adults is 6 mg. The dose may"/>
 <result pre="Recommendation 7. We conditionally recommend using serotonin antagonists such as" exact="ondansetron" post="to abort symptoms of a CVS episode Vote: 100%"/>
 <result pre="and anticipatory nausea and vomiting. 70, 71 Studies indicate that" exact="ondansetron" post="is as effective as other 5‐HT 3 receptor antagonists"/>
 <result pre="antagonists in the treatment of CINV. 72 The committee recommends" exact="ondansetron" post="as a first‐line agent in aborting an episode of"/>
 <result pre="to initiating this medication. We recommend using 8 mg of" exact="ondansetron" post="as a sublingual preparation or rectally (reformulated) at the"/>
 <result pre="an episode of vomiting. 4.3 Recommendation 8. We conditionally recommend" exact="aprepitant" post="to abort symptoms of a CVS episode Grade: Conditional"/>
 <result pre="&amp;gt;80% agreement There is a single open‐label trial of oral" exact="aprepitant" post="used as abortive treatment of CVS in children and"/>
 <result pre="mg daily for the following 2 days as needed. Oral" exact="aprepitant" post="could be retained if administered during a prodrome at"/>
 <result pre="tolerated. There are no data on the use of intravenous" exact="fosaprepitant" post="(phosphorylated prodrug of aprepitant) in CVS, although it has"/>
 <result pre="children and adolescents and positive clinical experience, the committee recommends" exact="aprepitant" post="as a potentially effective second‐line abortive agent. We recommend"/>
 <result pre="the onset of vomiting. The target individuals in whom abortive" exact="aprepitant" post="is recommended include those who are refractory to standard"/>
 <result pre="include those who are refractory to standard abortive therapy (eg," exact="sumatriptan" post="and ondansetron) and those who have a defined prodrome"/>
 <result pre="which occurs in relation to the menstrual cycle) in which" exact="aprepitant" post="can be initiated a day or two before the"/>
 <result pre="anticipated onset of vomiting. Difficulties with obtaining insurance approval for" exact="aprepitant" post="and IV fosaprepitant have been a barrier to its"/>
 <result pre="vomiting. Difficulties with obtaining insurance approval for aprepitant and IV" exact="fosaprepitant" post="have been a barrier to its use despite demonstrated"/>
 <result pre="2. We conditionally recommend that adults with moderate‐to‐severe CVS receive" exact="topiramate" post="as an alternate prophylactic medication (very low‐quality evidence) 3."/>
 <result pre="3. We conditionally recommend that adults with moderate‐to‐severe CVS receive" exact="aprepitant" post="as an alternate prophylactic medication (very low‐quality evidence) 4."/>
 <result pre="4. We conditionally recommend that adults with moderate‐to‐severe CVS receive" exact="zonisamide" post="or levetiracetam as an alternate prophylactic medication (very low‐quality"/>
 <result pre="conditionally recommend that adults with moderate‐to‐severe CVS receive zonisamide or" exact="levetiracetam" post="as an alternate prophylactic medication (very low‐quality evidence) 5."/>
 <result pre="(very low‐quality evidence) 5. We conditionally recommend using Co‐Q10, and" exact="riboflavin" post="as prophylactic therapy in the treatment of CVS. Mitochondrial"/>
 <result pre="(very low‐quality evidence) 6. We conditionally recommend using triptans like" exact="sumatriptan" post="to abort symptoms of a CVS episode. (moderate‐quality evidence)"/>
 <result pre="evidence) 7. We conditionally recommend using serotonin antagonists such as" exact="ondansetron" post="to abort symptoms of a CVS episode (consensus statement)"/>
 <result pre="of a CVS episode (consensus statement) 8. We conditionally recommend" exact="aprepitant" post="to abort symptoms of a CVS episode (very low‐quality"/>
 <result pre="(dose and duration) and response to medications TCAs such as" exact="amitriptyline" post="Anti‐epileptic drugs (topiramate, zonisamide, and levetiracetam) NK1 receptor antagonists"/>
 <result pre="studies of the abdomen Abortive medications such as triptans and" exact="ondansetron" post="and anxiolytics are most effective when used early in"/>
 <result pre="it is preferable to opt for the use of intravenous" exact="ketorolac" post="and non‐opiate sedation to avoid development of dependence or"/>
 <result pre="for a 70 kg adult.) For vomiting and nausea IV" exact="ondansetron" post="8 mg IV × 1—may repeat q 4‐6 h"/>
 <result pre="8 mg IV × 1—may repeat q 4‐6 h if" exact="ondansetron" post="is ineffective Consider diphenhydramine 50 mg IV and metoclopramide"/>
 <result pre="1—may repeat q 4‐6 h if ondansetron is ineffective Consider" exact="diphenhydramine" post="50 mg IV and metoclopramide 10 mg IV Consider"/>
 <result pre="if ondansetron is ineffective Consider diphenhydramine 50 mg IV and" exact="metoclopramide" post="10 mg IV Consider IV fosaprepitant 150 mg if"/>
 <result pre="50 mg IV and metoclopramide 10 mg IV Consider IV" exact="fosaprepitant" post="150 mg if available For sedation IV lorazepam 1‐2"/>
 <result pre="Consider IV fosaprepitant 150 mg if available For sedation IV" exact="lorazepam" post="1‐2 mg and b. IV diphenhydramine 50 mg for"/>
 <result pre="available For sedation IV lorazepam 1‐2 mg and b. IV" exact="diphenhydramine" post="50 mg for additional sedation For migraine‐like presentation Sumatriptan"/>
 <result pre="or Sumatriptan subcutaneous injection 6 mg/0.5 mL For pain IV" exact="ketorolac" post="30 mg if &amp;gt; 60 minutes from onset; may"/>
 <result pre="as indicated above or admit patient Positive treatment response—discharge Continue" exact="ondansetron" post="(soluble tablets) q 6‐8 h × 24‐48 h if"/>
 <result pre="q 6‐8 h × 24‐48 h if initially effective Continue" exact="lorazepam" post="× 24‐48 h if initially effective Continue NSAIDs for"/>
 <result pre="Czorlich P , Nagaraj C , et al. Amitriptyline and" exact="carbamazepine" post="utilize voltage‐gated ion channel suppression to impair excitability of"/>
 <result pre="Prophylactic therapy of cyclic vomiting syndrome in children: comparison of" exact="amitriptyline" post="and cyproheptadine: a randomized clinical trial . Am J"/>
 <result pre="Effective prophylactic therapy for cyclic vomiting syndrome in children using" exact="amitriptyline" post="or cyproheptadine . Pediatrics. 1997; 100: 977‐ 981. 9374568"/>
 <result pre="therapy for cyclic vomiting syndrome in children using amitriptyline or" exact="cyproheptadine" post=". Pediatrics. 1997; 100: 977‐ 981. 9374568 23 Boles"/>
 <result pre="29 Baldessarini RJ , Willmuth RL . Psychotic reactions during" exact="amitriptyline" post="therapy. Can Psychiatr Assoc J. 1968; 13: 571‐ 573."/>
 <result pre="open‐label study to evaluate the dosing, effectiveness, and safety of" exact="topiramate" post="as monotherapy in the treatment of epilepsy in clinical"/>
 <result pre="Kim WJ , et al. Long‐term efficacy and tolerability of" exact="topiramate" post="as add‐on therapy in refractory partial epilepsy: an observational"/>
 <result pre="course of adverse events in patients with localization‐related epilepsy receiving" exact="topiramate" post="added to carbamazepine . Epilepsia. 2005; 46: 648‐ 653."/>
 <result pre="events in patients with localization‐related epilepsy receiving topiramate added to" exact="carbamazepine" post=". Epilepsia. 2005; 46: 648‐ 653. 15857429 36 El"/>
 <result pre=", Mikati MA . Long‐term patterns of weight changes during" exact="topiramate" post="therapy: an observational study. Neurology. 2007; 69: 310‐ 311."/>
 <result pre="D , Grabnar I , et al. Effect of long‐term" exact="topiramate" post="therapy on serum bicarbonate and potassium levels in adult"/>
 <result pre="al. Equivalent dynamic human brain NK1‐receptor occupancy following single‐dose i.v." exact="fosaprepitant" post="vs. oral aprepitant as assessed by PET imaging ."/>
 <result pre="human brain NK1‐receptor occupancy following single‐dose i.v. fosaprepitant vs. oral" exact="aprepitant" post="as assessed by PET imaging . Clin Pharmacol Ther"/>
 <result pre="E , et al. Efficacy of the neurokinin‐1 receptor antagonist" exact="aprepitant" post="in children with cyclical vomiting syndrome . Aliment Pharmacol"/>
 <result pre="28. 49 Deshpande LS , Delorenzo RJ . Mechanisms of" exact="levetiracetam" post="in the control of status epilepticus and epilepsy. Front"/>
 <result pre="GS , Lustman PJ , Prakash C . Zonisamide or" exact="levetiracetam" post="for adults with cyclic vomiting syndrome: a case series."/>
 <result pre="Schuh‐Hofer S , Einhaupl KM , Arnold G . High‐dose" exact="riboflavin" post="treatment is efficacious in migraine prophylaxis: an open study"/>
 <result pre=", LeCates S , Bentti AL . Effectiveness of nasal" exact="sumatriptan" post="in 5‐ to 12‐year‐old children. Headache. 2001; 41: 693‐"/>
 <result pre="Wakusawa K , Haginoya K , et al. Efficacy of" exact="sumatriptan" post="in two pediatric cases with abdominal pain‐related functional gastrointestinal"/>
 <result pre="507. 21147834 65 Calhoun AH , Pruitt AP . Injectable" exact="sumatriptan" post="for cyclic vomiting syndrome in adults: a case series."/>
 <result pre="Caparroz C , Castro PC . Granisetron is equivalent to" exact="ondansetron" post="for prophylaxis of chemotherapy‐induced nausea and vomiting: results of"/>
 <result pre="KL . Comparative efficacy and safety of ondansetron, droperidol, and" exact="metoclopramide" post="for preventing postoperative nausea and vomiting: a meta‐analysis ."/>
</results>
